Keith Katkin, PEO, CEO/Urovant Sciences, Inc at Urovant Sciences Ltd. (UROV), sold 120,000 shares at $12.78 ($1.5M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $1.5M UROV by PEO, CEO/Urovant Sciences, Inc. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SNDX | BUY | 2025-05-19 | $91K | — | Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |